Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Preferred Dividend Payments (2016)

Historic Preferred Dividend Payments for Iovance Biotherapeutics (IOVA) over the last 1 years, with Q3 2016 value amounting to $49.5 million.

  • Iovance Biotherapeutics' Preferred Dividend Payments changed N/A to $49.5 million in Q3 2016 from the same period last year, while for Dec 2017 it was $49.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $49.5 million for FY2016, which is N/A changed from last year.
  • As of Q3 2016, Iovance Biotherapeutics' Preferred Dividend Payments stood at $49.5 million.
  • Iovance Biotherapeutics' Preferred Dividend Payments' 5-year high stood at $49.5 million during Q3 2016, with a 5-year trough of $49.5 million in Q3 2016.